CHMP recommends expansion of EU label for Hemlibra to include people with moderate haemophilia A December 16, 2022January 20, 2023 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: European Commission approves label expansion of…Interim data from phase III HAVEN 6 study…New data from phase III HAVEN 6 study reinforce…Quanterix Receives Label Expansion On Emergency Use…New data for Roche’s Hemlibra reinforce safety…CHMP recommends EU approval of Roche’s Polivy…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
